In spite of a punishing week, the 29 Reddit stocks with short interests in excess of 30% (see previous TalkMarkets article here) remain 35% above pre-squeeze levels, on average, with just one exception and 12 of the stocks actually increased in price. This article takes a look at the high short interest stock activity this past week.

All in all, the 29 stocks have declined 29% since the squeeze began around January 15th, with the major decliners being as follows.

1. GameStop (GME) was down 80% for the week but it is still up 80% from when the short squeeze really started in the earnest beginning just 3 weeks ago.
2. KOSS (KOSS) was down 69% last week but is up 589% from its January 15th price. 
3. Vaxart (VXRT) was down 67% and is now only up 7% since the squeeze began.
4. Naked Brand (NAKD) was down 33% but remains 144% above where it was 3 weeks ago.
5. National Beverage (FIZZ) was down 28% but is still up 23% in the last 3 weeks
6. Bed, Bath & Beyond (BBBY) was down 25% and is now back to where it was 3 weeks ago
7. Sun Power (SPWR) was down 19% but is still up 36% from 3 weeks ago
8. B&G Foods (BGS) was down 14% and is up 15% from January 15th
9. Stitch Fix (SFIX) was also down 14% last week and remains 11% greater than 3 weeks ago
10.  Tanger (SKT) was down 11% but is still up by 8.6% from when the squeeze began.

Another way to look at how the high short interest stocks are doing is to track those short interest stocks that have continued to increase in price and, in doing so, remain thorns in the side of the short-sellers. The major advancers last week were:

1. Fulgent Genetics (FLGT) +28% 
2. Accelerate Diagnostics (AXDX) +27%
3. Car Parts.com (PRTS) +22%
4. Clovis Oncology (CLVS) +18%
5. Ligand Pharma (LGND) +10%
6. Esperion Therapeutics (ESPR) +8%

Only one of the remaining 13 high net short stocks, Macerich (MAC), is currently down from where it was 3 weeks ago with the other 12 stocks only changing in price by +/-10% since then. 

Selling could continue in many of these names through the coming week but the buying support indicates this past week suggests that we are unlikely to see the above stocks move down quickly to what Wall Street would consider a fair valuation.